cancer-drug

Inside, a few protesters shouted criticism of FDA cancer-drug chief Richard Pazdur .

Avastin Caught in Debate Alicia Mundy 2011

But two follow-up studies funded by Genentech showed minimal if any delay in tumor growth and "nowhere near five months," said FDA cancer-drug chief Richard Pazdur in an interview in January.

Showdown Over Use of Cancer-Drug Avastin Alicia Mundy 2011

At Pfizer's cancer-drug laboratories in San Diego, researchers begin their projects by looking to see if tumors have specific molecular targets that can be treated more precisely.

Pfizer's Future: A Niche Blockbuster Jonathan D. Rockoff 2011

Dr. Pazdur, the FDA cancer-drug chief, spoke to the panel Tuesday and said Avastin is mostly used in combination with paclitaxel, "a known effective chemotherapy agent," which he said could explain some patients' positive stories.

Avastin Caught in Debate Alicia Mundy 2011

I-Spy 2's effort to bring much higher standards of productivity to cancer-drug development is inspired partly by Dr. Esserman's experience at business school.

A New Rx for Medicine Ron Winslow 2010

But two follow-up studies funded by Genentech showed minimal if any delay in tumor growth and "nowhere near five months," said FDA cancer-drug chief Richard Pazdur in an interview in January.

Showdown Over Use of Cancer-Drug Avastin Alicia Mundy 2011

The cancer-drug shortage involves chemotherapy drugs that were developed decades ago.

Drug Shortages Threaten Cancer Research Jennifer Corbett Dooren 2011

The rise in cancer-drug prices is a microcosm of broader trends pushing up health care costs nationally.

Democracy's Vices, Arnold Kling | EconLog | Library of Economics and Liberty 2009

The Swiss company eventually acquired U.S. cancer-drug maker Genentech in 2009 by forcing buyout talks with such an approach.

Roche Upbeat on Outlook as Profit Rises Sten Stovall 2012

Instead, Geron, whose shares have traded below $7 for the past two years, said it needed to save its cash for the cancer-drug trials.

Geron's Stem-Cell Exit Arose From Financial Uncertainty Peter Loftus 2011